Trial intelligence / Profile preview

Itopride to prevent lubiprostone-associated nausea in chronic constipation

jRCT1091220151Completed

Sponsor
Matsuda Hospital
Start
Nov 2013
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial of mosapride in chronic constipation and nausea ((none)) (2 arms), sponsored by Matsuda Hospital. Primary endpoint: Incidence of nausea events. Started Nov 2013; status: completed.

02

Drugs

mosapride
03

Conditions

chronic constipationnausea ((none))

Beyond the preview

Go deeper on jRCT1091220151.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1091220151.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call